Generali Asset Management’s United Therapeutics UTHR Stock Holding History

Generali Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$568K	Sell	1,048 -2,310	-69%	-$1.3M	0.01%	395
2026 Q1	$1.99M	Buy	3,358 +384	+13%	+$191K	0.04%	295
2025 Q4	$1.45M	Sell	2,974 -1,654	-36%	-$770K	0.03%	360
2025 Q3	$1.94M	Sell	4,628 -1,587	-26%	-$534K	0.04%	316
2025 Q2	$1.79M	Sell	6,215 -1,486	-19%	-$444K	0.04%	335
2025 Q1	$2.37M	Sell	7,701 -823	-10%	-$282K	0.06%	283
2024 Q4	$3.01M	Buy	+8,524	New	+$3.13M	0.08%	250

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Generali Asset Management's UTHR Position: Q2 2026 in Review

Generali Asset Management reduced its United Therapeutics (UTHR) stake by 69% in Q2 2026, selling an estimated $1.3M and leaving 1,048 shares worth $568K. The position accounts for 0.01% of the portfolio, ranked #395.

Generali Asset Management first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.01M in Q4 2024. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Generali Asset Management held 1,048 shares of United Therapeutics worth $568K as of Q2 2026.
Generali Asset Management sold 2,310 United Therapeutics shares in Q2 2026, an estimated $1.3M.
United Therapeutics made up 0.01% of Generali Asset Management's portfolio in Q2 2026, its #395 holding.
Generali Asset Management first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
Generali Asset Management's United Therapeutics position peaked at $3.01M in Q4 2024.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.